Table 2 Days to approval for countries under the VHP system and transition from VHP to CTIS (Bari-SolidAct), and for an initial application under CTIS (AXL-SolidAct and MOSAIC)
From: Experiences and challenges with the new European Clinical Trials Regulation
Country | Bari-SolidAct VHP | Bari-SolidAct Transition | AXL-SolidAct Initial CTIS | MOSAIC Initial CTIS |
|---|---|---|---|---|
Austria | 253 | 71 | - | - |
Belgium | 168 | 48 | 77 | 41 |
Czechia | 182 | 51 | 84 | - |
France | 83 | 43 | 78 | 41 |
Germany | 211 | 48 | - | - |
Greece | 92 | 43 | 79 | - |
Hungary | 120 | 48 | - | - |
Ireland | 174 | 51 | 98 | 86 |
Italy | 110 | 48 | - | 16 |
Luxembourg | 217 | 56 | 80 | - |
The Netherlands | - | - | - | 56 |
Norway | 91 | 43 | 80 | 82 |
Portugal | 184 | 43 | - | 51 |
Slovakia | 141 | 44 | 83 | - |
Spain | 148 | 44 | 79 | 42 |